Pulsed taVNS-elicited pupil dilation: effects of intermixed stimulation, sham location and respiratory phase

This study demonstrates that while pulsed transcutaneous auricular vagus nerve stimulation (taVNS) can elicit pupil dilation in intermixed experimental designs, the effect's dependence on sham location and lack of respiratory phase modulation challenge the assumption that it is mediated by the vagal afferent pathway.

The Gist

Imagine your brain has a master control center for "alertness" called the Locus Coeruleus (let's call it the "Wake-Up Switch"). When this switch is flipped, your pupils (the black dots in your eyes) get bigger, just like a camera opening its lens to let in more light when you're excited or focused.

Scientists have long believed they could flip this switch from the outside by zapping a specific part of the ear (the cymba concha) with a tiny electrical current. This technique is called taVNS. The idea is that this electrical zap travels up a nerve called the vagus nerve, hits the brainstem, and flips the "Wake-Up Switch," causing your pupils to dilate.

However, there were two big problems with how scientists were testing this:

1. The "Separate Rooms" Problem: They usually tested the real zap and a fake zap (sham) in separate blocks of time. It's like testing a new energy drink on Monday and a placebo on Friday. Your mood, tiredness, or stress levels might be totally different on those two days, messing up the results.
2. The "Wrong Control" Problem: They usually used the earlobe for the fake zap. But the earlobe is very different from the real target area. It's like testing a new car engine by comparing it to a bicycle wheel. They aren't built the same, so the comparison isn't fair.

The Study: A New Way to Test
Martin Kolnes and Sander Nieuwenhuis decided to fix these problems with two experiments.

Experiment 1: The Long Pulse
They tried mixing the real zap and the fake zap randomly in the same session (like flipping a coin for every trial). They used a long zap (3.4 seconds).

• The Result: It was a bit of a mess. They couldn't clearly tell if the real zap was working better than the fake one. It was like trying to hear a whisper in a noisy room; the signal was too weak.

Experiment 2: The Short Pulse & The Better Control
They made three big changes:

1. Shorter Zap: They shortened the zap to just 1 second. This is more like a quick "tap" on the shoulder, which fits better with fast brain experiments.
2. Two Fake Groups: They split participants into two groups.
   • Group A got the fake zap on the earlobe (the old way).
   • Group B got the fake zap on the scapha (a different part of the upper ear that looks like the real target but doesn't have the vagus nerve). This is like comparing the new engine to a different engine of the same size, rather than a bicycle.
3. Breathing Check: They watched how people breathed, because breathing might change how the brain reacts.

The Big Discoveries

1. The "Short Tap" Works (But Only with the Old Fake)
When they used the short 1-second zap and compared it to the earlobe fake, the pupils got significantly bigger. This is great news! It means scientists can now mix real and fake zaps in the same fast-paced experiment without ruining the data.

2. The "Better Fake" Ruins the Story
Here is the twist: When they compared the real zap to the scapha fake (the better control), the effect disappeared. The pupils didn't get bigger with the real zap compared to the fake one.

• The Metaphor: Imagine you think a magic wand makes flowers grow. You test it against a stick (earlobe), and the flowers grow! But then you test it against a different magic wand (scapha) that looks just as magical, and suddenly, the flowers don't grow any more than they did with the fake wand. This suggests the "magic" wasn't the wand at all; maybe it was just the feeling of being zapped.

3. Breathing Didn't Help
Scientists thought that zapping the ear while you exhale (breathe out) would work best because that's when the vagus nerve is most active. But it didn't matter. The pupils reacted the same way regardless of whether you were breathing in or out. This is another clue that the "vagus nerve path" might not be the one doing the work.

The Conclusion: What Does This Mean?
This paper is a bit of a "plot twist" for the field.

• Good News: We can now do these experiments faster and mix the real and fake zaps together, which is great for studying how the brain works in real-time.
• Bad News (for the theory): The evidence that the vagus nerve is the specific pathway causing the pupils to dilate is shaky. When they used a better control (the scapha), the effect vanished.

The Takeaway:
It seems that zapping the ear does make your pupils bigger, but it might not be because of the vagus nerve. It might be because the brain is reacting to the sensation of the zap itself, or because of other nerves in the ear that we haven't accounted for yet. It's like finding out that a "magic" light switch turns on the lights, but when you try it on a different switch that looks identical, it works too. Maybe the whole house is just wired to turn on when anyone touches the wall, not just that specific switch.

The authors are calling for more research to figure out exactly which wires are actually flipping the switch.

Technical Summary

1. Problem Statement

Transcutaneous auricular vagus nerve stimulation (taVNS) is a non-invasive method used to stimulate the locus coeruleus–norepinephrine (LC–NE) system, often measured via pupil dilation. While previous studies have established that pulsed taVNS can increase pupil size, two critical methodological limitations hinder its integration into rapid, event-related cognitive neuroscience tasks:

1. Experimental Design: Most prior studies delivered active taVNS and sham stimulation in separate blocks or sessions. This introduces confounds related to arousal, fatigue, and task engagement, which significantly affect baseline pupil size.
2. Mechanistic Uncertainty: It remains unclear whether taVNS-induced pupil dilation is truly mediated by the vagus nerve–nucleus tractus solitarius (NTS)–LC pathway or by non-specific sympathetic activation. Previous studies often used the earlobe as a sham location, which may have different sympathetic nerve densities compared to the active site (cymba concha), potentially failing to control for non-vagal sensory inputs.

The authors aimed to determine if taVNS effects on pupil dilation persist when active and sham trials are intermixed within the same block, and to critically test the vagal mediation hypothesis by varying sham location and respiratory phase.

2. Methodology

The study consisted of two experiments using a between-subjects design with eye-tracking (60 Hz) and respiration monitoring.

• Participants:
  • Experiment 1: $N=39$ (after exclusion).
  • Experiment 2: $N=59$ (after exclusion), split into two groups: Earlobe Sham ($n=30$) and Scapha Sham ($n=29$).
• Stimulation Protocol:
  • Active Site: Left cymba concha (targeting the auricular branch of the vagus nerve).
  • Sham Sites:
    • Experiment 1 & Exp 2 (Earlobe Group): Left earlobe.
    • Experiment 2 (Scapha Group): Left upper scapha (a non-vagal area with similar sympathetic nerve density to the cymba concha).
  • Parameters: Monophasic pulses, 25 Hz, 200–300 $\mu$s pulse width.
  • Duration:
    • Exp 1: 3.4 seconds per trial.
    • Exp 2: 1.0 second per trial (to better fit event-related designs).
  • Intensity: Individually calibrated to a subjective rating of 9/10 (just below pain) for both active and sham sites to ensure matched perceived intensity.
• Design:
  • Intermixed Trials: Active and sham trials were randomly intermixed within blocks (unlike previous block-wise designs).
  • Respiration: In Experiment 2, a respiration belt monitored the respiratory cycle (inhalation vs. exhalation) to test if stimulation during exhalation (known to enhance NTS activation) produced larger pupil responses.
• Analysis:
  • Pupil size was converted to percentage change relative to a 500ms pre-stimulus baseline.
  • Statistical analysis included non-parametric Wilcoxon signed-rank tests, mixed ANOVAs, and Bayesian t-tests (using Bayes Factors, $BF_{10}$) to quantify evidence for/against the alternative hypothesis.

3. Key Results

Experiment 1 (3.4s Stimulation, Intermixed)

• Result: Inconclusive evidence for taVNS-induced pupil dilation.
• Data: While frequentist tests showed a significant difference ($p = .029$), Bayesian analysis yielded only "anecdotal evidence" ($BF_{10} = 1.46$).
• Interpretation: The 3.4-second duration combined with intermixed trials may have led to carry-over effects or desensitization, weakening the observable effect compared to previous block-wise studies.

Experiment 2 (1.0s Stimulation, Intermixed)

• Sham Location Effect:
  • Earlobe Group: Strong evidence for taVNS efficacy ($BF_{10} = 14.86$). Pupil dilation was significantly larger for taVNS ($5.68\%$) than sham ($3.54\%$).
  • Scapha Group: Moderate evidence for the null hypothesis ($BF_{01} = 3.77$). There was no significant difference between taVNS ($4.77\%$) and sham ($4.27\%$).
• Respiratory Phase Effect:
  • Baseline: Pupil size naturally varied across the respiratory cycle (larger during mid-inhalation/exhalation, smaller during end-exhalation/inhalation), replicating Schaefer et al. (2025).
  • Stimulation Modulation: Contrary to the hypothesis that vagal activation is enhanced during exhalation, no interaction was found between respiratory phase and stimulation type. TaVNS did not produce a larger pupil response specifically during exhalation compared to sham.

4. Key Contributions

1. Feasibility of Intermixed Designs: The study demonstrates that pulsed taVNS effects on pupil dilation can be preserved in rapid, event-related designs where active and sham trials are intermixed, provided the stimulation duration is short (1 second).
2. Critical Challenge to the Vagal Pathway Hypothesis:
   • The finding that taVNS effects disappear when the scapha (a sympathetic-matched, non-vagal control) is used as the sham suggests the pupil response may not be specific to vagal activation.
   • The lack of an exhalation-specific enhancement contradicts the expected physiological signature of the vagus-NTS-LC pathway.
3. Methodological Refinement: The paper highlights the importance of matching sympathetic nerve density in sham locations and controlling for respiratory phase, which acts as a confound for baseline pupil size.

5. Significance and Conclusion

The authors conclude that while pulsed taVNS (1s duration) effectively increases pupil dilation in intermixed designs, the mechanism remains questionable.

• The "Earlobe Problem": The robust effect seen with earlobe sham may be an artifact of the earlobe having lower sympathetic nerve density than the cymba concha, making the sham stimulus less potent than the active stimulus in a non-vagal way.
• Pathway Doubt: The absence of a specific respiratory modulation (exhalation advantage) and the null result with the scapha sham suggest that taVNS-induced pupil dilation might be driven by general somatosensory or sympathetic activation rather than the specific vagus-NTS-LC pathway.

Implication: Cognitive neuroscientists can use intermixed taVNS protocols for rapid tasks, but they must interpret pupil dilation as a marker of general arousal or sensory processing rather than a specific proxy for LC-NE activity mediated by the vagus nerve, until more direct neural evidence (e.g., invasive recordings) clarifies the pathway. Future studies should prioritize scapha sham controls and investigate the specific neural mechanisms further.